Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Katigbak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
G3 (Bethesda, Md.)|March 10, 2018
Inducible Genome Editing with Conditional CRISPR/Cas9 MiceAlexandra Katigbak, Francis Robert, Marilène Paquet, et al.
Scientific Reports|December 17, 2016
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor SuppressorsAlexandra Katigbak, Regina Cencic, Francis Robert, et al.
Methods in Enzymology|November 16, 2014
Adapting CRISPR/Cas9 for functional genomics screensAbba Malina, Alexandra Katigbak, Regina Cencic, et al.
Cell Reports|May 31, 2016
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4AJennifer Chu, Gabriela Galicia-Vázquez, Regina Cencic, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
G3 (Bethesda, Md.)|March 10, 2018
Inducible Genome Editing with Conditional CRISPR/Cas9 MiceAlexandra Katigbak, Francis Robert, Marilène Paquet, et al.
Scientific Reports|December 17, 2016
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor SuppressorsAlexandra Katigbak, Regina Cencic, Francis Robert, et al.
Methods in Enzymology|November 16, 2014
Adapting CRISPR/Cas9 for functional genomics screensAbba Malina, Alexandra Katigbak, Regina Cencic, et al.
Cell Reports|May 31, 2016
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4AJennifer Chu, Gabriela Galicia-Vázquez, Regina Cencic, et al.
Pageof 1